LBL-015 / Leads Biolabs 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LBL-015 / Leads Biolabs
NCT05107011: Phase I/II Clinical Trial of LBL-015 for Injection

Completed
1/2
25
RoW
LBL-015 for Injections, LBL-015
Nanjing Leads Biolabs Co.,Ltd, Shanghai East Hospital, Shandong Cancer Hospital and Institute, Henan Cancer Hospital, Hunan Cancer Hospital, The First Affiliated Hospital of Nanchang University, First Affiliated Hospital Bengbu Medical College
Advanced Malignant Tumor
12/23
12/23

Download Options